Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Virtu Financial Inc. Class A Common Stock (VIRT) Price & Performance

Edgewise Therapeutics Inc. Common StockTrade
Virtu Financial Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Edgewise Therapeutics Inc. Common Stock vs Virtu Financial Inc. Class A Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while Virtu Financial Inc. Class A Common Stock trades at $55.56 (market cap $4.94B). The key difference: Virtu Financial Inc. Class A Common Stock is the larger of the two by market cap, and Virtu Financial Inc. Class A Common Stock pays a 1.72% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Virtu Financial Inc. Class A Common Stock for 6 Days on average.

EWTXVIRT
Market Cap
$3.94B$4.94B
Volume
810,1041,546,091
Sector
HealthFinancials
52-Week High
$48.35$67.93
52-Week Low
$14.89$32.53
Typical Hold Time
0 Days6 Days
Enterprise Value
$3.48B$14.65B
Dividend Yield
—1.72%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Edgewise Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Virtu Financial Inc. Class A Common Stock

VIRT trades at $55.94, down 1.46% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a P/E of 9.29, net income margin of 13.5%, and ROE of 31.65%. Recent expansion into Saudi Exchange block trading and consistent earnings outperformance support growth prospects. Analyst consensus price target is $63.00 with mixed ratings (38% buy, 46% hold).

VIRT presents a value opportunity with attractive valuation metrics and strong profitability, though technical indicators suggest near-term pressure. The company's market-making business demonstrates resilience with improving cash flow trends. Key risks include market volatility sensitivity and competitive pressures in financial services.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWTX
100% Buy0% Sell
Avg holding period · 0 Days
VIRT

No sentiment data available yet.

Top news

Latest headlines on both assets

About Edgewise Therapeutics Inc. Common Stock

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.

Read more on EWTX →

About Virtu Financial Inc. Class A Common Stock

Virtu Financial provides technology-enabled market-making and execution services. Its platforms help institutional, retail, and other market participants trade across global financial markets.

Read more on VIRT →